-
Genetic Refinement of Streptomyces for Pure 400-Isovalerylsp
2026-06-03
The reference study introduces a precise genetic deletion to engineer Streptomyces spiramyceticus for the exclusive production of 400-isovalerylspiramycin I, simplifying the macrolide antibiotic's composition. This innovation addresses manufacturing and quality control challenges, offering a streamlined platform for antimicrobial resistance research and pharmaceutical development.
-
Branched Endosomal Disruptor Lipids Enhance mRNA Delivery Ef
2026-06-03
This study introduces a new class of branched ionizable lipids (BENDs) that significantly improve endosomal escape, resulting in more efficient delivery of mRNA and CRISPR-Cas9 complexes for hepatic gene editing and T cell engineering. The findings carry important implications for the design of next-generation lipid nanoparticles, potentially enabling more effective and safer mRNA-based therapeutics.
-
Metformin HCl Inhibits Tendon Ossification via Nr4a1/Wnt Pat
2026-06-02
This study demonstrates that Metformin Hydrochloride (Metformin HCl) suppresses heterotopic ossification in mouse Achilles tendon by downregulating Nr4a1 and inhibiting Wnt/β-catenin signaling. The findings reveal a novel anti-osteogenic mechanism for metformin, suggesting therapeutic potential in musculoskeletal pathologies beyond its canonical metabolic effects.
-
UTP Solution: Precision RNA Synthesis & Epigenetic Insights
2026-06-02
UTP Solution (100 mM) from APExBIO delivers ultra-pure uridine-5'-triphosphate trisodium salt, empowering sensitive in vitro transcription, RNA amplification, and siRNA synthesis workflows. With unmatched purity and DNase/RNase-free assurance, it is the reagent of choice for molecular biology teams exploring RNA regulation, epigenetic mechanisms, and metabolic pathways.
-
EZ Cap Cy5 Firefly Luciferase mRNA: Dual-Mode mRNA Tracking
2026-06-01
EZ Cap™ Cy5 Firefly Luciferase mRNA (5-moUTP) enables real-time visualization and quantification of mRNA delivery, translation, and intracellular trafficking with exceptional sensitivity. Its unique Cap1 capping, 5-moUTP modification, and Cy5 labeling set a new benchmark for robust, low-immunogenicity readouts in gene expression and vaccine research.
-
Filipin III: Precision Polyene Macrolide Antibiotic for Chol
2026-06-01
Filipin III sets the gold standard for high-resolution cholesterol detection in biological membranes, combining robust workflow flexibility with unmatched specificity. This article details applied use-cases, advanced workflows, and troubleshooting strategies, empowering researchers to harness Filipin III’s unique properties for membrane cholesterol visualization.
-
HyperScribe™ Kit Plus 1: Raising the Bar for Clinical-Grade
2026-05-31
Discover how the HyperScribe All in One mRNA Synthesis Kit Plus 1 advances ARCA-capped mRNA synthesis for translational research. This article uniquely bridges clinical-grade workflow design with insights from recent immuno-oncology breakthroughs.
-
Integrated Protocols for mRNA Lipid Nanoparticle Evaluation
2026-05-30
Ma et al. present a comprehensive protocol for formulating, characterizing, and evaluating mRNA lipid nanoparticles (LNPs), aiming to lower technical barriers in the field. Their stepwise workflow supports reproducible mRNA LNP production and assessment, facilitating translational research in diverse applications.
-
Phosphotungstic Acid Negative Stain Solution for Virus Imagi
2026-05-29
Harness the power of 2% Phosphotungstic Acid Negative Stain Solution for high-contrast visualization of viruses, macromolecules, and microbial structures in electron microscopy. This guide demystifies workflow optimization, troubleshooting, and the translation of novel lectin-based viral imaging insights into practical lab protocols.
-
JC-1 Mitochondrial Membrane Potential Assay Kit: Advanced Wo
2026-05-29
Unlock robust, ratiometric mitochondrial membrane potential analysis with the JC-1 Mitochondrial Membrane Potential Assay Kit. This guide delivers expert workflow enhancements, troubleshooting, and translational insights for apoptosis and immunomodulation research.
-
28S rRNA Expansion Segments Shape Multilayered Nucleolar Arc
2026-05-28
Wei et al. reveal that expansion segments in 28S rRNA are key determinants of the multilayered architecture of the nucleolus, functioning as modular elements that drive complex RNA-RNA interactions. Their mechanistic dissection provides new insight into the evolution of nucleolar structure and offers a framework for reconstituting layered nucleolar assemblies in vitro.
-
tFUS Modulates Nespas/miR-383-3p/SHP2 Axis in Post-Stroke Ne
2026-05-28
This study demonstrates that transcranial focused ultrasound stimulation (tFUS) alleviates NLRP3-driven neuroinflammation after ischemic stroke by upregulating the Nespas/miR-383-3p/SHP2 pathway. The findings highlight SHP2 as a critical mediator of microglial inflammatory responses and suggest new molecular targets for post-stroke therapy.
-
Prestained Protein Marker (Triple color, EDTA free, 10-250 k
2026-05-27
The Prestained Protein Marker (Triple color, EDTA free, 10-250 kDa) addresses rapid, visual protein sizing and transfer monitoring in SDS-PAGE and Western blot workflows while maintaining compatibility with EDTA-sensitive protocols. This product should not be used for post-electrophoresis protein recovery or absolute protein quantification.
-
Ethacridine Lactate Monohydrate: Precision Antiseptic Use in
2026-05-27
Ethacridine lactate monohydrate (7-ethoxyacridine-3,9-diamine) delivers high-purity, rapid-action antiseptic control for advanced cell and chromatin assays. Its solubility profile and validated mechanism enable reproducible workflows where microbial inhibition is non-negotiable. Integrated troubleshooting and workflow guidance make it the gold standard for contamination-free, epigenetic and differentiation studies.
-
ATRA Overcomes PARP Inhibitor Resistance in Ovarian Cancer
2026-05-26
This study demonstrates that all-trans retinoic acid (ATRA) sensitizes epithelial ovarian cancer (EOC) cells to PARP inhibitors following cisplatin exposure by downregulating a resistance-associated molecular signature and reducing intracellular NAD+ levels. The findings reveal a promising new maintenance strategy for improving outcomes in platinum-resistant EOC and suggest that modulating NAD metabolism is a viable research direction.